RORA and ovarian cancer: The inhibition of ECM1 expression was also observed to rescue cell migration and angiogenesis (Supplementary Figure 1D-E) and to restore the glucose uptake and lactate, ATP, and NADPH efficacy of PS VII against PARP inhibitor-resistant ovarian cancer cells under RORα downregulation (Supplementary Figure 1F).